Published in Am J Med Sci on December 17, 1983
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2013) 2.27
Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg (1990) 1.90
A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry. J Thromb Haemost (2006) 1.71
Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab (1997) 1.55
Effects of feeding on protein turnover in healthy children and in children with cystic fibrosis. Am J Clin Nutr (1996) 1.52
Somatostatin decreases diarrhea in patients with the short-bowel syndrome. J Clin Gastroenterol (1982) 1.50
Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract (1993) 1.38
Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J Nutr (1983) 1.30
Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ (1994) 1.30
Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel. Dig Dis Sci (1995) 1.29
Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med (1985) 1.24
Somatostatin inhibits diarrhea in the carcinoid syndrome. Ann Intern Med (1980) 1.19
Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab (1975) 1.15
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology (1988) 1.09
Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg (1990) 1.07
Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology (1980) 1.06
Effect of octreotide acetate on pancreatic exocrine function. Am J Surg (1989) 1.06
Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab (1974) 1.04
Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol (1983) 1.03
Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides (1993) 1.01
Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J Surg Res (1991) 0.99
Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase. J Immunol (1981) 0.99
Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe. Surgery (1993) 0.98
Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Ann Intern Med (1985) 0.98
Intraoperative localization of intestinal arteriovenous malformation. Arch Surg (1978) 0.97
Early surgical treatment of gastrinoma. Am J Med (1987) 0.97
Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med (1983) 0.97
Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. Lancet (1986) 0.96
Prevention of postprandial hypotension with somatostatin. Ann Intern Med (1985) 0.96
Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med (1986) 0.96
Display of arteriovenous anastomoses by double latex injection after vasodilatation with chloroform. Microvasc Res (1970) 0.96
Mechanisms of action of long-acting analogs of somatostatin. Regul Pept (1993) 0.95
Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides. Am J Dig Dis (1976) 0.95
Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology (1977) 0.94
Selective release of gastric inhibitory polypeptide by intraduodenal amino acid perfusion in man. Gastroenterology (1978) 0.94
Somatostatin receptor gene expression in neuroblastoma. Regul Pept (2000) 0.94
Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass. Surgery (1986) 0.94
Gastric response to severe head injury. Am J Surg (1984) 0.93
Chronic renal failure: effect of hemodialysis on gastrointestinal hormones. Am J Surg (1984) 0.93
Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes (1990) 0.93
Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man. Gastroenterology (1977) 0.93
The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci (1995) 0.93
Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol (1999) 0.93
Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion. Gastroenterology (1976) 0.93
Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. J Lab Clin Med (1980) 0.93
Renal effects on serum gastric inhibitory polypeptide (GIP). Metabolism (1977) 0.92
Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors. Surg Gynecol Obstet (1988) 0.92
Benign parotid enlargement in bulimia. Ann Intern Med (1980) 0.92
Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome. J Clin Endocrinol Metab (1981) 0.92
Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies. Neurosurgery (1993) 0.91
GI hormonal changes in diabetes influence pancreatic cancer growth. J Surg Res (1995) 0.91
Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. N Engl J Med (1981) 0.91
Thirty years' experience with gastrinoma. World J Surg (1984) 0.91
Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab (1999) 0.90
Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus. Diabetes (1976) 0.90
Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog. J Pediatr (1987) 0.90
Angiotensin II and norepinephrine antagonize the secretory effect of VIP in rat ileum and colon. Peptides (1984) 0.89
Treatment of hypercalcemia associated with malignancy. Semin Oncol (1978) 0.89
Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care (1984) 0.89
Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995. Am J Med (1987) 0.89
Serum insulin and glucose concentrations in people at risk for type II diabetes. A comparative study of African Americans and Nigerians. Diabetes Care (1993) 0.88
Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol (1986) 0.88
Amyloidosis, diarrhea, and a somatostatin analogue. Ann Intern Med (1989) 0.88
Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transport in vivo. Dig Dis Sci (1979) 0.88
Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts. Regul Pept (1983) 0.88
Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Invest Ophthalmol Vis Sci (2001) 0.88
Release of vasoactive intestinal polypeptide by electrical field stimulation of rabbit ileum. Regul Pept (1981) 0.87
Growing vascular endothelial cells express somatostatin subtype 2 receptors. Br J Cancer (2001) 0.87
Neurotensin, vasoactive intestinal peptide, and Roux-en-Y gastrojejunostomy. Their role in the dumping syndrome. Arch Surg (1985) 0.87
Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci (1982) 0.87
Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome. J Clin Endocrinol Metab (1983) 0.86
Short-term infusion of pancreatic polypeptide: effect on children with Prader-Willi syndrome. Am J Clin Nutr (1990) 0.86
Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery (1996) 0.85
The causes of cancelled elective surgery. Qual Assur Util Rev (1990) 0.85
Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med (1979) 0.85
A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy. Int J STD AIDS (2009) 0.85
VIPoma syndrome. Semin Oncol (1987) 0.84
Endocrine tumors--special problems in diagnosis and management. Semin Oncol (1987) 0.84
Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J Surg Res (1990) 0.84
Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport. Ann Intern Med (1985) 0.84
A methanol poisoning outbreak in Kentucky. A clinical epidemiologic study. Arch Environ Health (1968) 0.84
The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab (1976) 0.84
Vasoactive intestinal polypeptide mediates cholecystokinin-induced relaxation of the sphincter of Oddi. J Clin Invest (1988) 0.84
Vasoactive intestinal peptide and neuropeptide modulation of the immune response. J Immunol (1985) 0.84
Chief cells possess somatostatin receptors regulated by secretagogues acting through the calcium or cAMP pathway. Am J Physiol (1994) 0.84
Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab (1980) 0.83